Top Markets
Coin of the day
Athens Medical C.S.A. Athens Medical C.S.A.

Athens Medical C.S.A.

IATR
Rank in Stocks #19369
Athens Medical C.S.A., together with its affiliated companies, operates and... Athens Medical C.S.A., together with its affiliated companies, operates and holds ownership of hospital facilities both within Greece and on an international scale. The organization delivers extensive diagnostic and treatment options for various cancers, such as those affecting the breast, gastrointestinal system, blood, liver and pancreas, lungs, prostate, skin, bladder, kidneys, and female reproductive organs. Additionally, it offers advanced robotic surgery, neurosurgical procedures, spinal operations, and therapies for cardiac ailments. Its services encompass a broad range of orthopedic specialties, addressing conditions of the foot and ankle, hand and wrist, hip, knee, shoulder, and spine, in addition to treating sports-related injuries. The company also provides care for chronic conditions including diabetes, endocrine disorders, heart failure, high blood pressure, pain management, respiratory system issues, stroke, and thyroid conditions. Furthermore, Athens Medical C.S.A. runs wellness and preventative health centers and performs cosmetic and reconstructive plastic surgery. The group is also involved in medical education, training, and practical service provision, alongside offering patient care guidance. It currently manages eight hospital units, which collectively feature 1,200 beds. Founded in 1984, Athens Medical C.S.A. is headquartered in Athens, Greece.
Share Price
$1.90
Last synced: 2026-08-25
Market Cap
$164.61M
Change (1 day)
-1.23%
Change (1 year)
-24.88%
Country
GR
Trade Athens Medical C.S.A. (IATR)

Category

P/B ratio for Athens Medical C.S.A. (IATR)
P/B ratio as of 2026 TTM: 0
According to Athens Medical C.S.A. latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for Athens Medical C.S.A. from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors